Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia

Fig. 3

The Kaplan–Meier plot of cardiovascular outcomes in patients with HeFH. A The cumulative event-free survival analysis in patients with and without physical signs (TX/CA); B the cumulative event-free survival analysis among four mutation subgroups (group1: TX/CA(−), Mu(−); group2: TX/CA(−), Mu(+); group3: TX/CA(+), Mu(−); group4: TX/CA(+), Mu(+)). TX: tendon xanthomas; CA: corneal arcus; Mu: mutation; Mu(+): mutation positive; Mu(−): mutation negative

Back to article page